Amylyx Pharmaceuticals Inc. share price logo

Amylyx Pharmaceuticals Inc.

NASDAQ: AMLX

Mid Cap

$23.68

+1.00

(+4.43%)

Live

as on

Amylyx Pharmaceuticals Inc. Stock Performance

as on August 12, 2026 at 4:11 am IST

  • Day's Low

    Day's High

    $22.19
    $23.70
    downward going graph

    6.29%

    Downside

    0.08%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $7.61
    $24.60
    downward going graph

    67.88%

    Downside

    3.89%

    Upside

    downward going graph

Amylyx Pharmaceuticals Inc. share price movements today

Previous Close
$22.67
Open
$22.92
Volume
249.0K
Day's Low - High
$22.19 - $23.70
52 Week Low - High
$7.61 - $24.60

Amylyx Pharmaceuticals Inc. Historical Returns

1 Month Return
+ 27.57 %
3 Month Return
+ 52.35 %
1 Year Return
+ 189.9 %
3 Year Return
+ 4.95 %
5 Year Return
0 %

Amylyx Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Amylyx Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.5B

EPS (TTM)

-1.4362

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-161.7M

Revenue (TTM)

-665.0K

Profit Margin

0.00%

Return On Equity TTM

-74.73%

Amylyx Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Amylyx Pharmaceuticals Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Amylyx Pharmaceuticals Inc. image
Amylyx Pharmaceuticals Inc.
BUY$2.5BNANA0.00%NA
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$23.1B161.94%19.341.56%NA
Viatris Inc. image
Viatris Inc.
HOLD$18.9B9.85%NA-2.79%2.9499999999999997%
Haleon plc (ADR) image
Haleon plc (ADR)
BUY$44.2BNA20.4714.55%1.97%
ZOETIS INC. image
ZOETIS INC.
BUY$30.0B-62.09%11.8527.69%2.67%
See all

Stock Returns calculator for Amylyx Pharmaceuticals Inc. Stock including INR - Dollar returns

The Amylyx Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Amylyx Pharmaceuticals Inc. investment value today

Current value as on today

₹3,29,671

Returns

₹2,29,671

(+229.67%)

Returns from Amylyx Pharmaceuticals Inc. Stock

₹2,02,813 (+202.81%)

Dollar Impact

₹26,858 (+26.86%)

Analyst Recommendation on Amylyx Pharmaceuticals Inc. Stock

Based on 13 analysts

BUY

53.85%

Buy

46.15%

Hold

0.00%

Sell

Based on 13 analysts, 53.85% of analysts recommend a 'BUY' rating for Amylyx Pharmaceuticals Inc.. Average target price of $27.44

Amylyx Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Amylyx Pharmaceuticals Inc..

What analysts predicted

13.7%UPSIDE

Target Price

$27.44

Current Price

$23.68

Analyzed by

13 Analysts

Target

$27.44

Amylyx Pharmaceuticals Inc. target price $27.44, a slight upside of 13.7% compared to current price of $23.68. According to 13 analysts rating.

Indian Investors' Interest in Amylyx Pharmaceuticals Inc. Stock

Search interest for Amylyx Pharmaceuticals Inc. Stock has increased by 74% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:74% versus previous 30 day period

Amylyx Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
88
-1
0
0
-
-
-
-
-
-
Gross Profit
-27
-8
0
0
-22
0
-19
0
0
-
Operating Income
-122
-53
-75
-40
-37
-42
-36
-36
-43
-45
EBITDA
-118
-72
-72
-38
-35
-41
-34
-30
-41
-43
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-118
-72
-72
-38
-35
-41
-34
-32
-41
-43
Income Tax Expense
0
-
-72
0
-
-
-
0
-
-
Net Income
-118
-72
-72
-37
-35
-41
-34
-32
-41
-43
Net Profit Margin
-134.01%
7106.55%
-17476.92%
5646.02%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Amylyx Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
0
0
22
380
87
-
Gross Profit
-10
-23
0
19
355
45
0
Operating Income
-13
-39
-82
-201
38
-314
-153
EBITDA
1
-39
-82
-200
55
-290
-144
Interest Expense
1
2
0
4
-
-
-
Depreciation
-
0
0
0
1
0
0
Income Before Tax
-13
-42
-87
-197
54
-302
-144
Income Tax Expense
1
2
0
0
5
0
0
Net Income
-14
-42
-87
-198
49
-301
-144
Net Profit Margin
-1038.99%
-6504.62%
-30834.74%
-892.38%
12.94%
-345.36%
0.00%

Amylyx Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-72
-72
-37
-35
-41
-34
-32
-41
-43
Operating Cash Flow
-66
-41
-59
-39
-25
-30
-27
-36
-31
Investing Cash Flow
-28
38
64
-43
22
5
29
36
-149
Financing Cash Flow
0
0
0
65
0
191
0
3
1
Change in Cash
-95
-2
5
-17
-1
167
1
2
-178

Amylyx Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-42
-87
-198
49
-301
-144
Operating Cash Flow
-36
-74
-179
11
-167
-123
Investing Cash Flow
0
-46
-238
92
75
14
Financing Cash Flow
46
158
431
3
0
257
Change in Cash
9
37
12
107
-92
148

Global Institutional Holdings in Amylyx Pharmaceuticals Inc.

Funds
Holdings
Perceptive Advisors LLC
7.44%
First Light Asset Management, LLC
2.86%
Driehaus Capital Management LLC
2.68%
Citadel Advisors Llc
1.39%
Geode Capital Management, LLC
1.98%
See all

Insights on Amylyx Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, AMLX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, AMLX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, AMLX stock has moved up by 27.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 416.0K → -665.0K (in $), with an average decrease of 259.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -32.99M → -43.42M (in $), with an average decrease of 15.1% per quarter

About Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provides Avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol which is phase 2 clinical trial for the treatment of wolfram syndrome, as well as in phase 2b/3 clinical trial to treat progressive supranuclear palsy; AMX0114, which is in phase 1 clinical trial for the treatment of amyotrophic lateral sclerosis; and long-acting GLP-1 receptor antagonist to treat post-bariatric hypoglycemia and other rare diseases. Further, it develops AMX0318, a GLP-1 receptor antagonist for the treatment of post-bariatric hypoglycemia and other rare diseaees. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
OrganisationAmylyx Pharmaceuticals Inc.
Headquarters55 Cambridge Parkway, Cambridge, MA, United States, 02142
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Joshua B. Cohen
E-voting on sharesClick here to vote

Key Management of Amylyx Pharmaceuticals Inc.

Name

Title

Ms. Linda A. Arsenault

Chief Human Resources Officer

Mr. Joshua B. Cohen

Co-Founder, Co-CEO & Director

Dr. Camille L. Bedrosian M.D.

Chief Medical Officer

Mr. Tom Holmes

Chief Technical Operations Officer

Ms. Lindsey Allen

Head of Investor Relations & Communications

Ms. Gina M. Mazzariello J.D.

Chief Legal Officer & General Counsel

Ms. Tammy Sarnelli

Global Head of Regulatory Affairs

Dr. Machelle Manuel Ph.D.

VP & Head of Global Medical Affairs

Mr. Justin B. Klee

Co-CEO & Director

Mr. James M. Frates M.B.A.

Chief Financial Officer

FAQs

What is Amylyx Pharmaceuticals Inc. share price today?

Amylyx Pharmaceuticals Inc. share price today is $23.68 as on . Amylyx Pharmaceuticals Inc. share today touched a day high of $23.70 and a low of $22.19.

What is the 52 week high and 52 week low for Amylyx Pharmaceuticals Inc. share?

Amylyx Pharmaceuticals Inc. share touched a 52 week high of $24.60 on and a 52 week low of $7.61 on . Amylyx Pharmaceuticals Inc. stock price today i.e. is trending at $23.68,which is 3.74% down from its 52 week high and 211.37% up from its 52 week low.

What is Amylyx Pharmaceuticals Inc.'s market capitalisation today?

Amylyx Pharmaceuticals Inc. market capitalisation is $0.00T as on .

How to invest in Amylyx Pharmaceuticals Inc. Stock (AMLX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Amylyx Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amylyx Pharmaceuticals Inc. Shares that will get you 0.0633 shares as per Amylyx Pharmaceuticals Inc. share price of $23.68 per share as on August 11, 2026 at 10:41 pm IST.

What is the minimum amount required to buy Amylyx Pharmaceuticals Inc. Stock (AMLX) from India?

Indian investors can start investing in Amylyx Pharmaceuticals Inc. (AMLX) shares with as little as ₹95.435 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹954.35 in Amylyx Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Amylyx Pharmaceuticals Inc. share’s latest price of $23.68 as on August 11, 2026 at 10:41 pm IST, you will get 0.4223 shares of Amylyx Pharmaceuticals Inc.. Learn more about fractional shares .